Recombinant Human Il1a Protein，His

Interleukin-1 alpha (IL-1α) is a key cytokine in the immune response, playing a crucial role in the regulation of inflammation and the activation of immune cells. It is primarily produced by activated macrophages and epithelial cells, and is involved in a wide array of biological processes, including cellular proliferation, differentiation, and apoptosis. The dysregulation of IL-1α is linked to various inflammatory diseases, autoimmune disorders, and even cancer, making it a significant target for therapeutic interventions. Research on recombinant IL-1α has gained momentum due to its potential applications in understanding these diseases and developing novel treatments. By producing recombinant IL-1α, scientists aim to explore its functional properties, investigate its signaling pathways, and evaluate its effects on various cell types in vitro and in vivo. Furthermore, recombinant IL-1α can be utilized in drug development, vaccine formulation, and therapeutic strategies for managing diseases associated with aberrant IL-1 signaling. The growing interest in targeted therapies has fueled studies on its structure-function relationship and the development of IL-1α inhibitors, indicating its promise in improving clinical outcomes for patients suffering from IL-1-related pathologies. Overall, the research on recombinant IL-1α continues to advance our understanding of its crucial role in immune modulation and highlights its relevance in developing effective therapeutic strategies for diverse diseases.